© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
March 18, 2020
Recently, many providers have become worried about the potential of certain medications to worsen transmission and outcomes in the setting of the global COVID-19 pandemic.
December 16, 2019
Results of the DAPA-HF trial demonstrate the efficacy and safety of dapagliflozin in patients with heart failure.
December 03, 2019
Staying on top of oral hygiene may be connected to a lower risk of atrial fibrillation and heart failure.
December 02, 2019
A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events.
November 15, 2019
In honor of World Diabetes Day, AstraZeneca has launched the campaign Diabetes Can Break Your Heart, the national movement aimed to change the trajectory of heart failure in type 2 diabetes.
May 28, 2019
The PHARM-CHF trial investigated whether regularly seeing a pharmacist improves adherence to heart failure medications.
December 18, 2018
November 12, 2018
Top news of the day from across the health care landscape
November 30, 2017
“The central problem in heart failure is not that patients are short of breath or retain fluid. The problem is that they die.”
November 16, 2017
The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.